Skip to main content
. Author manuscript; available in PMC: 2010 Apr 1.
Published in final edited form as: Schizophr Res. 2009 Feb 15;109(1-3):24–37. doi: 10.1016/j.schres.2009.01.016

Table 5.

Mean percent abnormal, effect size, and 95% CI for physiological abnormalities.

Endophenotype: Niacin Flush
%Abnormal N Effect Size 95% CI N
Oral Administration
SCZ 43.2 2 0.6 0.64-0.64 2
HC 1.7 2 N/A N/A 0
Topical Administration
SCZ 60.7 4 0.7 0.26-1.17 5
REL 28.0 2 N/A N/A 0
HC 24.4 5 N/A N/A 0

N = number of studies included; N/A = not applicable; unable to calculate based on available published data